ApoGen Biotechnologies Overview
- Founded
-
2014
- Status
-
Out of Business
- Employees
-
10
- Latest Deal Type
-
Out of Business
ApoGen Biotechnologies General Information
Description
Developer of advanced therapies intended to break drug resistance in cancer. The company develops therapies that target key drivers of ongoing deoxyribonucleic acid mutation and tumor evolution, enabling physicians to slow or stop cancer genome mutation.
Contact Information
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 2815 Eastlake Avenue East
- Suite 300
- Seattle, WA 98102
- United States
ApoGen Biotechnologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Out of Business | 25-May-2021 | 0000 | Completed | Out of Business | ||
| 3. Secondary Transaction - Private | 0000 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 23-Aug-2018 | $11M | $11M | 000.00 | Completed | Generating Revenue |
| 1. Seed Round | Completed | Startup |
ApoGen Biotechnologies Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 0,000,000 | 00.000000 | 00 | 00 | 00 | 00 | 00.000 |
ApoGen Biotechnologies Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of advanced therapies intended to break drug resistance in cancer. The company develops therapies that target
Drug Discovery
Seattle, WA
10
As of 2021
0000
00000000 00
0000
000000
d tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, q
0000 000000000
San Carlos, CA
00
As of 0000
00000
000000000
00000
000000
ectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore ma
0000000000000
South San Francisco, CA
000
As of 0000
00000
00000000
00000
Add Comparison
ApoGen Biotechnologies Competitors (73)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Apexigen | Formerly VC-backed | San Carlos, CA | 00 | 00000 | 000000000 | 00000 |
| 000000 00000000000 | Formerly VC-backed | South San Francisco, CA | 000 | 00000 | 00000000 | 00000 |
| 00000000 000000000 | Formerly VC-backed | San Diego, CA | 000 | 00000 | 0000000000. | |
| 0000000 0000000000 | Venture Capital-Backed | Maastricht, Netherlands | 0 | 000.00 | 00000 00000 | 000.00 |
| 000000000 | Formerly VC-backed | Gaithersburg, MD | 00 | 00000 | 00000000 | 00000 |
ApoGen Biotechnologies Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
